Reuters logo
BRIEF-Kite Pharma names Richard Wang CEO of Fosun Kite Biotechnology Co Ltd
March 5, 2017 / 9:30 PM / 7 months ago

BRIEF-Kite Pharma names Richard Wang CEO of Fosun Kite Biotechnology Co Ltd

March 5 (Reuters) - Kite Pharma Inc :

* Richard L. Wang named chief executive officer of Fosun Kite Biotechnology Co, Ltd, a joint venture to lead development of axicabtagene ciloleucel and other engineered T-cell therapies for treatment of cancers in China

* Richard wang named CEO of Fosun Kite Biotechnology Co Ltd Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below